Logo image of AGYS

AGILYSYS INC (AGYS) Stock Fundamental Analysis

USA - NASDAQ:AGYS - US00847J1051 - Common Stock

104.46 USD
-1.16 (-1.1%)
Last: 9/22/2025, 12:00:08 PM
Fundamental Rating

5

Overall AGYS gets a fundamental rating of 5 out of 10. We evaluated AGYS against 279 industry peers in the Software industry. While AGYS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AGYS is valued quite expensive, but it does show an excellent growth. These ratings could make AGYS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year AGYS was profitable.
In the past year AGYS had a positive cash flow from operations.
Of the past 5 years AGYS 4 years were profitable.
In the past 5 years AGYS always reported a positive cash flow from operatings.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.29%, AGYS is in the better half of the industry, outperforming 69.18% of the companies in the same industry.
AGYS's Return On Equity of 4.95% is fine compared to the rest of the industry. AGYS outperforms 68.82% of its industry peers.
The Return On Invested Capital of AGYS (7.28%) is better than 77.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AGYS is below the industry average of 11.86%.
The 3 year average ROIC (7.16%) for AGYS is below the current ROIC(7.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROIC 7.28%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

AGYS's Profit Margin of 4.85% is fine compared to the rest of the industry. AGYS outperforms 67.03% of its industry peers.
AGYS's Profit Margin has improved in the last couple of years.
AGYS has a better Operating Margin (9.14%) than 73.84% of its industry peers.
AGYS's Operating Margin has improved in the last couple of years.
AGYS has a Gross Margin (62.13%) which is comparable to the rest of the industry.
AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AGYS is destroying value.
Compared to 1 year ago, AGYS has more shares outstanding
Compared to 5 years ago, AGYS has more shares outstanding
The debt/assets ratio for AGYS is higher compared to a year ago.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 13.90 indicates that AGYS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 13.90, AGYS belongs to the best of the industry, outperforming 90.68% of the companies in the same industry.
AGYS has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
AGYS has a better Debt to FCF ratio (0.25) than 80.65% of its industry peers.
AGYS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, AGYS is in line with its industry, outperforming 59.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 13.9
ROIC/WACC0.64
WACC11.37%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.11 indicates that AGYS should not have too much problems paying its short term obligations.
AGYS's Current ratio of 1.11 is on the low side compared to the rest of the industry. AGYS is outperformed by 67.03% of its industry peers.
A Quick Ratio of 1.04 indicates that AGYS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.04, AGYS is doing worse than 69.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.04
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.33% over the past year.
The Earnings Per Share has been growing by 47.96% on average over the past years. This is a very strong growth
AGYS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.92%.
AGYS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.38% yearly.
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%

3.2 Future

Based on estimates for the next years, AGYS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.65% on average per year.
The Revenue is expected to grow by 21.76% on average over the next years. This is a very strong growth
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.70, the valuation of AGYS can be described as expensive.
AGYS's Price/Earnings is on the same level as the industry average.
AGYS is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 49.22, AGYS can be considered very expensive at the moment.
AGYS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, AGYS is valued quite expensively.
Industry RankSector Rank
PE 65.7
Fwd PE 49.22
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGYS is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as AGYS.
Industry RankSector Rank
P/FCF 62.14
EV/EBITDA 81.35
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AGYS may justify a higher PE ratio.
AGYS's earnings are expected to grow with 19.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.49
PEG (5Y)1.37
EPS Next 2Y16.64%
EPS Next 3Y19.65%

0

5. Dividend

5.1 Amount

AGYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGILYSYS INC

NASDAQ:AGYS (9/22/2025, 12:00:08 PM)

104.46

-1.16 (-1.1%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners102.65%
Inst Owner Change-1.82%
Ins Owners4.4%
Ins Owner Change0.13%
Market Cap2.93B
Analysts83.08
Price Target132.65 (26.99%)
Short Float %6.12%
Short Ratio7.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.18%
Min EPS beat(2)-10.75%
Max EPS beat(2)85.11%
EPS beat(4)3
Avg EPS beat(4)23.84%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)7
Avg EPS beat(8)23.11%
EPS beat(12)11
Avg EPS beat(12)23.04%
EPS beat(16)14
Avg EPS beat(16)21.73%
Revenue beat(2)2
Avg Revenue beat(2)1.53%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.95%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.18%
Revenue beat(12)5
Avg Revenue beat(12)-0.58%
Revenue beat(16)7
Avg Revenue beat(16)-0.94%
PT rev (1m)0.64%
PT rev (3m)11.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 65.7
Fwd PE 49.22
P/S 10.14
P/FCF 62.14
P/OCF 58.95
P/B 10.34
P/tB 38.99
EV/EBITDA 81.35
EPS(TTM)1.59
EY1.52%
EPS(NY)2.12
Fwd EY2.03%
FCF(TTM)1.68
FCFY1.61%
OCF(TTM)1.77
OCFY1.7%
SpS10.3
BVpS10.1
TBVpS2.68
PEG (NY)10.49
PEG (5Y)1.37
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROCE 8.03%
ROIC 7.28%
ROICexc 8.76%
ROICexgc 36.88%
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
FCFM 16.32%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.33
Cap/Depr 26.88%
Cap/Sales 0.88%
Interest Coverage 250
Cash Conversion 138.51%
Profit Quality 336.48%
Current Ratio 1.11
Quick Ratio 1.04
Altman-Z 13.9
F-Score5
WACC11.37%
ROIC/WACC0.64
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%
EBIT growth 1Y17.78%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year173.69%
EBIT Next 3Y69.32%
EBIT Next 5Y56.79%
FCF growth 1Y94.78%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y44.43%
OCF growth 3Y24.6%
OCF growth 5Y39.06%